The NHS Genomic Medicine Service (GMS) is a multi-professional, multidisciplinary service which delivers integrated pathways focused on patient need, whilst addressing quality, governance and supporting optimal outcomes for patients.
Each of the professions work together and contribute to the specific role and responsibilities of the Genomic Laboratory Hub (GLH) commissioned by NHS England to deliver the genomic testing for the NHS GMS as outlined in the National Genomics Test Directory (NGTD).
Cellular Pathology is integral to patient pathways, as it is responsible for tissue diagnostics and preparation for downstream genomic testing. Interpretation of genomic tests and incorporation into an integrated pathology report is increasingly required for a stratified approach to optimal patient management. Our North East and Yorkshire GLH (NEYGLH) service is provided collaboratively with Newcastle, Leeds and Sheffield, with genetics at NuTH also part of our Integrated Laboratory Medicine (ILM) directorate.
Newcastle CPGC was provided commissioned funding early in 2024 after being successful in the first bids from NHSE via the NEYGLH. After working closely with the North East and North Cumbria (NENC) Pathology network, we have been consolidating some testing pathways and worked collaboratively to standardise others, sharing protocols, improving request forms, and communicating developments to meet the main objective of offering equitable access to the NGTD for all patients in our region.